Question 1

Which is bigger, ABBV or PEN?

Accepted Answer

Abbvie Inc. is the larger company — market cap $488B vs $12.6B for Penumbra, Inc..

Question 2

Which is more profitable, ABBV or PEN?

Accepted Answer

PEN keeps more of each revenue dollar as profit — net margin 10.7% vs 9.8% for ABBV.

Question 3

Which stock is cheaper, ABBV or PEN?

Accepted Answer

On earnings, ABBV trades at a lower P/E — 77.4 vs 78.3 for PEN. A lower P/E means paying less per dollar of earnings.

Question 4

Which is the better stock — ABBV or PEN?

Accepted Answer

On reported financials, ABBV leads 4 of 9 comparable metrics and PEN leads 5. StockCV rates ABBV “Mixed” and PEN “Strong”. This is information, not investment advice — compare the full CVs before drawing conclusions.

Metric	ABBV	PEN
Price	$276.43	$319.40
Market cap	$488B	$12.6B
Revenue (TTM)	$64.4B	$1.50B
Revenue growth	+1.8%	+18.3%
Net margin	9.8%	10.7%
Free cash flow	$18.2B	$216M
Net cash (debt)	($56.2B)	—
1-year price return	+19.8%	+22.2%
P/E	77.4	78.3
P/E vs own history (cheap-side %)	23%	76%
Dividend yield	2.45%	—
Return on equity	96%	11%
Altman Z-score	2.33	18.49
CV checks passed	9 of 11	9 of 11
Employees	57,000	4,700

Abbvie Inc. vs Penumbra, Inc.